Skip to Main Content

Genomic Basis of Neurodevelopmental and Brain Outcomes in Congenital Heart Disease (CHD Brain and Genes)

Conditions

Diseases of the Cardiovascular System

What is the purpose of this trial?

Approximately 400 Congenital heart disease patients will participate in the research study which will include one or more research visits for neurodevelopmental testing, brain MRI, and collection of medical history including previously collected genetic sequencing results. The investigators will explore the association between genetic variants, neurodevelopmental deficits, and brain MRI endophenotype. Analyses will compare groups with and without deleterious de novo mutations.

  • Trial with
    National Institute of Child Health and Human Development (NICHD)
  • Start Date
    10/22/2017
  • End Date
    12/30/2027
Trial Image

For more information about this study, contact:

Nancy Cross

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    03/28/2018
  • Study HIC
    #2000020449